In this study, we demonstrate for the first time that the ceramide-degrading enzyme ACER3 is upregulated in NASH livers and that its upregulation contributes to the pathogenesis of Western-diet-induced NASH by exacerbating hepatocellular injury in response to oversupply of saturated fatty acids. This evidence concerns the gene ACER3 and metabolic dysfunction-associated steatohepatitis.